Pituitary tumors are not brain tumors.

From the desk of PWN cofounder Lewis S. Blevins, Jr. M D  - Social media has been a springboard for misinformation, and the spread...

October is Pituitary Awareness Month.

From the editor's desk - For organizations in the pituitary space, we believe it is critically important to reach out to a broader audience...

Critical insights on Diabetes Insipidus

PODCAST: Dr. Blevins takes an in-depth look at Diabetes Insipidus with a specific focus on diagnostic testing. In this podcast, you will be...

The frustrating process of insurance authorizations for the use of medicines

What happens when the insurance company's first line of response is to deny, deny, deny?  How does this increase in oversight from third-party payors...

Webinar: The complexities of hormone levels and symptoms of pituitary conditions

Two outstanding informational webinars were made available to Pituitary World News by Dr. Lewis Blevins, co-founder and medical director of the California Center for...

A look at the Orphan Drug Congress

Back In-Person! The Orphan Drug Congress, slated for this August 25 to 27 at the Gaylord National Resort & Convention Center, Oxon Hill, Maryland USA,...

The dangers and challenges of misinformation

From the desk of J D Faccinetti, co-founder, an op-ed - The whole thing about misinformation is that it is dangerous. More specifically, people can...

A new drug for acromegaly: an insider’s look at the clinical trial

With the recent launch announcement of the phase 3 trial for Paltusotine - Crinetics new nonpeptide oral drug candidate for acromegaly - we asked...

A Conversation with Acromegaly Patient Advocates

We recently sat down with members of the acromegaly community to discuss their treatment journeys and the lessons they learned along the way, including...

Big news for acromegaly at Crinetics

From the desk of J D Faccinetti - co-founder - The company recently kicked off a phase 3 trial for their new nonpeptide oral...

NEWS YOU CAN USE

Articles you may like